Sign inJoin waitlistJoin the waitlist

James Stoeckle

Network Physician, Medical Oncology, DFCI · Boston Medical Center-Brighton

Credentials: · · · · · ·

History

Dana-Farber Cancer Institute
2022–Present

New York University Medical Center
2019–2022
Internal Medicine
Beth Israel Deaconess Medical Center
2016–2019
Tulane University School of Medicine
2012–2016

Research

Chromothripsis as a pathogenic driver of multiple myeloma
Review · Seminars in Cell and Developmental Biology · 2022 · 34 citations
Stuttering: Clinical and research update
Review · Canadian family physician Medecin de famille canadien · 2016 · 34 citations
COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system
Cancer · 2021 · 31 citations

Faith Davies
4 papers
Gareth Morgan
4 papers
Louis Williams
4 papers · 3 as a fellow
BB
Benedetto Bruno
3 papers
FM
Francesco Maura
3 papers
Marc Braunstein
3 papers
Ola Landgren
3 papers
Yubao Wang
3 papers
Arnaldo Arbini
2 papers
Beatrice Razzo
2 papers · 2 as a fellow
Benjamin Diamond
2 papers
Daniel Becker
2 papers

Clinical trials

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Site PI · Recruiting · Phase 3
American Society of Clinical Oncology
2024–2028
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034